|
1
|
Jouffret L, Turrini O, Ewald J, Moutardier
V, Iovanna JL and Delpero JR: Long-term survivors after
pancreatectomy for cancer: The TNM classification is outdated. ANZ
J Surg. 85:860–864. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singh KE, Taylor TH, Pan CG, Stamos MJ and
Zell JA: Colorectal cancer incidence among young adults in
California. J Adolesc Young Adult Oncol. 3:176–184. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang SP and Wang LH: Disease implication
of hyper-Hippo signalling. Open Biol. 6:2016. View Article : Google Scholar
|
|
6
|
Wang Z, Liu P, Zhou X, Wang T, Feng X, Sun
YP, Xiong Y, Yuan HX and Guan KL: Endothelin promotes colorectal
tumorigenesis by activating YAP/TAZ. Cancer Res. 77:2413–2423.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang YP and Tang DX: Expression of
Yes-associated protein in liver cancer and its correlation with
clinicopathological features and prognosis of liver cancer
patients. Int J Clin Exp Med. 8:1080–1086. 2015.PubMed/NCBI
|
|
8
|
Wu H, Xie J, Pan Q, Wang B, Hu D and Hu X:
Anticancer agent shikonin is an incompetent inducer of cancer drug
resistance. PLoS One. 8:e527062013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shi S and Cao H: Shikonin promotes
autophagy in BXPC-3 human pancreatic cancer cells through the
PI3K/Akt signaling pathway. Oncol Lett. 8:1087–1089. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim HJ, Hwang KE, Park DS, Oh SH, Jun HY,
Yoon KH, Jeong ET, Kim HR and Kim YS: Shikonin-induced necroptosis
is enhanced by the inhibition of autophagy in non-small cell lung
cancer cells. J Transl Med. 15:1232017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qian HR and Yang Y: Functional role of
autophagy in gastric cancer. Oncotarget. 7:17641–17651. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Klionsky DJ, Abeliovich H, Agostinis P,
Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA,
Ballabio A, et al: Guidelines for the use and interpretation of
assays for monitoring autophagy in higher eukaryotes. Autophagy.
4:151–175. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fridlender M, Kapulnik Y and Koltai H:
Plant derived substances with anti-cancer activity: From folklore
to practice. Front Plant Sci. 6:7992015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou W, Jiang Hda G, Peng Y and Li SS:
Comparative study on enantiomeric excess of main akannin/shikonin
derivatives isolated from the roots of three endemic Boraginaceae
plants in China. Biomed Chromatogr. 25:1067–1075. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He G, He G, Zhou R, Pi Z, Zhu T, Jiang L
and Xie Y: Enhancement of cisplatin-induced colon cancer cells
apoptosis by shikonin, a natural inducer of ROS in vitro and in
vivo. Biochem Biophys Res Commun. 469:1075–1082. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Petherick KJ, Williams AC, Lane JD,
Ordóñez-Morán P, Huelsken J, Collard TJ, Smartt HJ, Batson J, Malik
K, Paraskeva C and Greenhough A: Autolysosomal β-catenin
degradation regulates Wnt-autophagy-p62 crosstalk. EMBO J.
32:1903–1916. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li YJ, Lei YH, Yao N, Wang CR, Hu N, Ye
WC, Zhang DM and Chen ZS: Autophagy and multidrug resistance in
cancer. Chin J Cancer. 36:522017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu T, Wang W, Zhang S, Stewart RA and Yu
W: Identifying tumor suppressors in genetic mosaics: The Drosophila
lats gene encodes a putative protein kinase. Development.
121:1053–1063. 1995.PubMed/NCBI
|
|
19
|
Wang X, Su L and Ou Q: Yes-associated
protein promotes tumour development in luminal epithelial derived
breast cancer. Eur J Cancer. 48:1227–1234. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Z, Zeng W, Wang S, Zhao X, Guo Y, Yu
P, Yin X, Liu C and Huang T: A potential role for the Hippo pathway
protein, YAP, in controlling proliferation, cell cycle progression,
and autophagy in BCPAP and KI thyroid papillary carcinoma cells. Am
J Transl Res. 9:3212–3223. 2017.PubMed/NCBI
|
|
21
|
Moroishi T, Hansen CG and Guan KL: The
emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 15:73–79.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mo JS, Park HW and Guan KL: The Hippo
signaling pathway in stem cell biology and cancer. EMBO Rep.
15:642–656. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao Y, Shi Q, Xu S, Du C, Liang L, Wu K,
Wang K, Wang X, Chang LS, He D and Gu P: Curcumin promotes KLF5
proteasome degradation through downregulating YAP/TAZ in bladder
cancer cells. Int J Mol Sci. 15:15173–15187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Oku Y, Nishiya N, Shito T, Yamamoto R,
Yamamoto Y, Oyama C and Uehara Y: Small molecules inhibiting the
nuclear localization of YAP/TAZ for chemotherapeutics and
chemosensitizers against breast cancers. FEBS Open Bio. 5:542–549.
2015. View Article : Google Scholar : PubMed/NCBI
|
